When Expertise Meets Family: A Neuroscientist's Personal Journey Through ALS and FTD

My Journey into the Heart of Neurodegenerative Disease

When I began my career as a neuropsychologist, I never imagined that the field I was entering would one day become intimately personal. My journey started in Bellville, Texas—a small town where few knew much about neurodegenerative diseases like dementia or ALS. It wasn't until I trained at the University of California, San Francisco's Memory and Aging Center that I truly understood what these conditions entailed. That experience shaped not only my professional path but also gave me a unique lens through which to view family dynamics during times of illness.

It was there I learned how frontotemporal dementia (FTD), a group of disorders affecting the frontal and temporal lobes, could lead to dramatic changes in personality, behavior, and cognition. As someone who had always been drawn to complex human interactions, I found myself naturally attuned to these cases—particularly those involving significant behavioral variants that don't fit the typical memory loss stereotype associated with dementia.

My family history added a particularly poignant layer to this work. My father was known for his sharp wit and strong character. He instilled in me the belief that I could be anything I wanted to be, setting the foundation for my confidence early on. Yet when he began experiencing mobility issues in 2003—attributed initially to back surgery complications—he also started showing signs of behavioral change. These shifts were subtle at first but became increasingly pronounced over time.

'I knew something was wrong, but didn't know exactly how the signs fit together,' I recall thinking as his condition worsened. At the time, I couldn't identify whether his symptoms pointed toward ALS or FTD due to limited awareness and research into the overlap between these diseases.

He passed away in 2011 at age 65, leaving behind a legacy of resilience that would later influence my own clinical approach and personal understanding of how families cope with neurodegenerative disease.

The Pain of Recognition

In 2021, I found myself once again confronting the reality of these conditions—but this time, in a deeply personal way. My aunt, who shared many of my father's traits, began showing signs of mobility difficulties. Her diagnosis was a sobering reminder of what we'd seen before. She was later identified as having familial ALS-FTD caused by a variant in the TARDBP gene—a rare mutation accounting for only two to five percent of familial ALS cases.

Knowing that her condition had genetic implications, I grappled with questions about whether I should pursue testing for myself and my daughters. This dilemma underscored how much more complex such decisions can be when the stakes are personal rather than academic or clinical. The emotional toll was immense. It forced me to confront not just the science behind these diseases but also the reality of what they mean for families.

Building Empathy Through Experience

The experience with my father and aunt has fundamentally changed how I approach patient care. No longer am I merely an observer of symptoms and clinical progress; I now understand the weight of uncertainty, fear, and grief that families carry when navigating these diagnoses.

I've seen countless patients struggle to communicate their experiences, and their loved ones do the same. But seeing this unfold in my own family allowed me to see things from both sides—the professional and the personal—and appreciate the immense challenge that comes with caring for someone affected by a rare neurodegenerative disease.

As I reflect on this journey, I'm struck by how little we know about ALS and FTD, despite decades of research. Many families spend years trying to understand what's happening to their loved ones without proper support or guidance. This realization has driven my commitment to advocacy, education, and ensuring that others aren't left to navigate these diseases alone.

Supporting Research and Community

One of the most meaningful moments in my aunt's journey was her decision to donate her brain for research after her death. Her daughters felt a profound sense of pride knowing that their mother's sacrifice would help future patients. This decision highlighted the importance of community involvement in advancing our understanding of these conditions.

I encourage all families facing similar diagnoses to consider participating in ongoing studies. Whether through genetic counseling, participation in clinical trials, or simply sharing their experiences, every contribution helps move the needle forward in developing better treatments and perhaps even cures for ALS and FTD.

There are also non-profit organizations doing critical work to support families impacted by these diseases. These groups provide not just resources but also a vital network of shared experience and emotional support during one of life's most difficult journeys.

Conclusion: A Call for Compassionate Understanding

As I continue my work at UT Health San Antonio's Glenn Biggs Institute, I carry with me the lessons learned from my own family's experience. The intersection of science and emotion is where real healing begins. While we may not have found a cure yet, the compassion and dedication shown by patients and families alike gives us hope for a future where these conditions are better understood, managed, and ultimately defeated.

My personal journey has taught me that while neurodegenerative diseases affect individual lives in profound ways, they also connect us across generations. They remind us of our shared humanity—the way we care for each other, support one another, and keep pushing forward even when the path ahead seems uncertain.